相关实验视频

Updated: Jul 14, 2025

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
07:17

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser

Published on: May 9, 2018

8.1K

新加坡良性前列腺增生症的替代一线和二线治疗方法的成本效益

Junxing Chay1, Joshua Yi Min Tung2, Rebecca Jade Su1

  • 1Health Services and Systems Research, Duke-NUS Medical School, Singapore, Singapore.

Journal of medical economics
|October 6, 2023
PubMed
概括

与医疗管理 (MM) 相比,水蒸气热疗法 (WVTT) 是良性前列腺增生 (BPH) 的成本效益高的第一线治疗方法. 前列腺尿道提升 (PUL) 不具有成本效益,而 TURP 对严重的BPH具有成本效益.

关键词:
良性前列腺增生症 良性前列腺增生症D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D 在线观看 在线观看 在线观看D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D6 D7 D7 D7 D8 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D1 D1 D1 D1 D1 D1D61 D61 D61 D61 这是一个很好的例子.我已经开始了,我已经开始了.第111章 这是一件好事在I1818年,马尔科夫模型的模型经济评估 经济评价增量性成本效益比率是一个增量性成本效益比率.水蒸气热疗法是一种水蒸气热疗法.

更多相关视频

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

19.2K
Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.06:04

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.

Published on: March 6, 2018

17.0K

相关概念视频

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
439
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
169
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
180